Newsroom

Sorted by: Latest

-

Marriott Vacations Worldwide Corporation Announces Third Quarter Earnings Release and Conference Call

ORLANDO, Fla.--(BUSINESS WIRE)--Marriott Vacations Worldwide Corporation (NYSE: VAC) will report financial results for the third quarter 2026 on Wednesday, November 4th and host a conference call at 8:30 a.m. ET that morning to discuss the Company’s results. Participants may access the call by dialing (877) 407-8289 or (201) 689-8341 for international callers. A live webcast of the call will also be available in the Investor Relations section of the Company’s website at ir.mvwc.com. An audio re...
-

Arrowhead Pharmaceuticals Granted Entry in the FDA STAR Pilot Program for Plozasiran in Severe Hypertriglyceridemia

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the United States Food and Drug Administration (FDA) has granted plozasiran entry in the Split Real Time Application Review (STAR) pilot program in connection with Arrowhead’s upcoming supplemental new drug application (sNDA) for severe hypertriglyceridemia (sHTG). SHTG is a condition that significantly increases the risk of acute pancreatitis, which is associated with repeated hospital admiss...
-

Bridg Strengthens Proprietary Identity Graph, Expanding the Data Foundation Behind PAR Intelligence

NEW HARTFORD, N.Y.--(BUSINESS WIRE)--Bridg, a PAR Technology Corporation (NYSE: PAR) company, today announced significant enhancements to its identity resolution platform, including a rebuilt proprietary identity graph, advanced matching capabilities, and a modernized data foundation behind PAR Intelligence, PAR's agentic intelligence layer. Its multi-source graph contains 255 million verified U.S. consumer identities, representing more than 90% of the U.S. adult population.Bridg helps brands co...
-

Inflammasome Therapeutics to Present New Phase 2 Analyses of K8 in Geographic Atrophy at AAO Retina Subspecialty Day

NEWTON, Mass.--(BUSINESS WIRE)--Inflammasome Therapeutics today announced that additional analyses from its Phase 2 study of Kamuvudine K8 in geographic atrophy will be presented at the American Academy of Ophthalmology (AAO) Retina Subspecialty Day in New Orleans on Friday 9 October 2026. Liangbo Shen, MD, will present “A Phase 2 Clinical Trial of the Inflammasome Inhibitor Kamuvudine K8 in Geographic Atrophy” at 5.00 pm CT. The six-month Phase 2 study evaluated K8 in 30 participants with bila...
-

Fertram Sigurjonsson and Team Launch Arctell at the Arctic Circle Assembly to Build the Next Generation of High North Companies

REYKJAVIK, Iceland & ISAFJORDUR, Iceland--(BUSINESS WIRE)--Business innovator, entrepreneur and Kerecis founder Fertram Sigurjonsson today announced the launch of Arctell, a High North innovation and investment platform dedicated to building globally competitive companies rooted in Arctic science, entrepreneurship and frontier innovation. Positioned at the intersection of Arctic resilience, science, entrepreneurship and long-term capital, Arctell’s mission is to connect founders, researchers, u...
-

DualEntry Is Now Available on the Silicon Valley Bank Offers Marketplace

NEW YORK--(BUSINESS WIRE)--DualEntry is now available through the Silicon Valley Bank (SVB) Offers marketplace, giving eligible new customers access to preferred pricing on DualEntry’s AI-native ERP. Through the offer, new customers can receive a discount on DualEntry, with savings of up to $20,000. DualEntry helps finance teams automate accounting work across areas including close, reporting, accounts payable, accounts receivable, consolidations, and multi-entity accounting. The platform is bu...
-

UK Debt Management Office UK Regulatory Announcement: Issue of Debt

LONDON--(BUSINESS WIRE)--    DMO-TAS041/3740/002         The Minster Building21 Mincing LaneLondonEC3R 7AG T 020 7862 6500F 020 7862 6509www.dmo.gov.uk           A134\26 7 October 2026   PRESS NOTICE   RESULT OF THE SALE BY TENDER OF UP TO £1500 MILLION OF 0⅛% TREASURY GILT 2028The United Kingdom Debt Management Office ("DMO") announces that the tender of up to £1,500 million of 0⅛% Treasury Gilt 2028 (ISIN Code: GB00BMBL1G81) has been allocated as follows:(Note: all prices in this notice are q...
-

KBRA Releases AI Credit: Data Centers in Focus—Credit Considerations Across Asset Classes Webinar Recap

NEW YORK--(BUSINESS WIRE)--KBRA releases a recap of its AI Credit: Data Centers in Focus—Credit Considerations Across Asset Classes webinar held on October 1. The event was co-hosted with Yulchon, a leading Korean law firm, and featured a number of KBRA experts from Corporate, Project and Infrastructure Finance, Structured Finance and APAC Ratings. The speakers examined how artificial intelligence (AI)-driven demand is reshaping data center and GPU credit across project finance, commercial mort...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Low Duration Global Government Bond UCITS ETF 06.10.2026 FGOV LN IE00BKS2X200 69,469.00 GBP 1,019,352.84 17.308  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust IPOX Europe Equity Opportunities UCITS ETF 06.10.2026 IPXE.IM IE00BFD26097 50,002.00 EUR 1,244,360.39 24.886  ...